Yasuaki Sagara

13PUBLICATIONS
36CO-AUTHORS
Environmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersPanel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 08, 2026
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.

|Jun 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

|Feb 02, 2026
<i>MAML2</i>-Rearranged Hidradenoma of the Breast: Clinicopathologic and Molecular Analysis of Four Patients.

Naomi Gondo, Yasuyo Ohi, Tsubasa Hiraki

|Dec 29, 2025
Postoperative course and safety profile of the suture scaffold technique in breast-conserving surgery: a single-institution observational study.

Reiko Mitsueda, Yasuyo Ohi, Yukari Mochitomi

|Sep 15, 2025
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study.

Yasuaki Sagara, Atsushi Yoshida, Yuri Kimura

|Jan 05, 2024
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan.

Yasuaki Sagara, Hiraku Kumamaru, Naoki Niikura

Pageof 3

Frequent Collaborators

4 joint publications

Tsuguo Iwatani

3 joint publications

Shigehira Saji

3 joint publications

Norikazu Masuda

2 joint publications

Sumito Saeki